RAP-103

N/A

Report date: 2025/10/09 20:00:09
NME

Base Information

Drug NameRAP-103
Drug Alias NameRAP-701RAP-164RAP-310RAP-163RAP-103 +[6] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionC-C chemokine receptor type 2 antagonistsC-C chemokine receptor type 5 antagonistsC-X-C motif chemokine receptor 4 antagonists
TargetsC-C chemokine receptor type 2C-C chemokine receptor type 5C-X-C motif chemokine receptor 4
Therapy Area/IndicationsPsoriasisNeuralgiaAlzheimer Disease +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMexico
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesRapid Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesClarent Biopharma Inc
Inactive CompaniesRapid Pharmaceuticals
Active IndicationsPsoriasis
Inactive IndicationsNeuralgiaAlzheimer DiseaseProstatic Neoplasms +[5] 

Other Information

ATC CodeN/A
Related LinksN/A